In March, Novartis purchased certain oncology and specialty medicines from GlaxoSmithKline (GSK). While this does not affect your current participation in either of the two programs below, please read the information carefully to understand what you must do to continue to access your medications.
Patient Assistance Program:
Free medicine for qualified patients
Co-pay Assistance (financial assistance for out-of-pocket costs for qualified patients) and Reimbursement Support Programs
If you are currently receiving free medicine through GSK's COMMITMENT to ACCESS program or are completing a new application to receive free medicine through such a program, you should complete and return a Release and Disclosure form prior to August 3, 2015. This form is required to continue receiving your product when the program transitions to the Novartis Patient Assistance Foundation, Inc.
If you have any questions about your participation in the COMMITMENT to ACCESS program and/or the Release and Disclosure form, please call the GSK helpline at 1-866-265-6491 between the hours of 8:30am-8pm EST.
For now, GSK will continue to manage co-pay assistance and reimbursement support for the COMMITMENT to ACCESS program to ensure a smooth transition to Novartis later in the year.
For participants who are currently receiving co-pay assistance or other reimbursement support, there are no actions to take right now. Participants will be notified and provided with more information when these program components transition.
If you have questions about enrollment in the COMMITMENT to ACCESS Co-pay Assistance and Reimbursement Support programs, please call the GSK helpline at 1-866-265-6491 between the hours of 8:30am-8pm ET.
To begin the enrollment process for GSK cancer or certain specialty medicines and determine your eligiblity.
GSK Counselors are available to assist you from 8:30am - 8:00pm EST at:
Assistance is available in Spanish and many other languages / La asistencia está disponible en español y muchos otros idiomas.